Found by the weekly check, waiting to be accepted. Nothing here is in the database yet.
| Company | Would change | Because it read | Source | |
|---|---|---|---|---|
| Adaptyv Bio | stage: — → Seed amount: — → USD 8M amount_note: — → $8 million seed round investors: — → Ace Ventures, ByFounders, Founderful, LongGame, angels lead_investor: — → Ace Ventures location: — → Lausanne | This announcement comes after the company raised its $8 million seed round led by Ace Ventures earlier this year. | startupticker.ch | |
| Adaptyv Biosystems | verification only | The company has closed a Series A funding round of $40 million led by Highland Europe with existing investors Ace Ventures , ByFounders and Y Combinator doubling down. | startupticker.ch | |
| Ahead Health | amount: — → USD 6M investors: — → RTP Global, Tiny.VC, Pareto 20 lead_investor: — → RTP Global location: — → Zurich | Ahead Health, the Zurich-based preventive healthcare company providing an AI-powered platform to democratise access to sophisticated preventative healthcare , has finalized its seed funding round, raising $6 million. | startupticker.ch | |
| Basilea Pharmaceutica | verification only | awarded USD 30 million in additional funding to Basilea after meeting its prespecified enrollment milestone | sg.finance.yahoo.com | |
| Cy Biopharma | stage: — → Acquisition amount_note: — → expected gross proceeds at initial close of concurrent private placement by acquirer Ensysce, before fees; plus up to a $38.6M follow-on tranche location: — → Zug | Ensysce Biosciences, a clinical-stage company developing a new class of highly novel opioids for the treatment of severe pain, has acquired Zug-based Cy Biopharma, a clinical-stage biotechnology company focussed on novel neuroplastogenic therapies for severe chronic pain disorders. The acquisition is structured as a stock-for-stock merger. | startupticker.ch | |
| Gravis Robotics | verification only | Today, Gravis Robotics has officially announed a $200M investment from SoftBank Investment Advisers, the largest ever Series A raised in construction robotics history. | startupticker.ch | |
| Immitra Bio | lead_investor: — → Backbone Ventures location: — → Geneva | Geneva-based Immitra Bio has secured an upsized CHF 2.4 million pre-seed financing round to accelerate the development of its scalable in-vivo gene editing platform and lead therapeutic candidate, IB-003, a potential one-time curative treatment for an inherited anemia. | venturelab.swiss | |
| NovaGo Therapeutics AG | verification only | today announced the successful completion of a CHF 24 million (USD 30 million) Series B financing round | prnewswire.com | |
| Prem | verification only | Swiss artificial intelligence startup Prem SA is raising $100 million in Series A funding at a valuation of at least $500 million, Bloomberg reported today . The round is expected to close in the third quarter. | siliconangle.com | |
| Terra Quantum | amount_note: — → not stated in source; only a $3.25 billion valuation is disclosed investors: — → Mountain Lake Acquisition Corp. II lead_investor: — → Mountain Lake Acquisition Corp. II location: — → St. Gallen | Terra Quantum AG ("Terra Quantum"), a leading quantum technology company, and Mountain Lake Acquisition Corp. II ("MLAC II") (Nasdaq: MLAA ), a special purpose acquisition company, today announced that they have signed a non-binding letter of intent ("LOI") to enter into a business combination that values Terra Quantum at $3.25 billion. | prnewswire.com | |
| Vaderis Therapeutics | verification only | today announced the closing of a private $152 million Series B financing | prnewswire.com | |
| Valuemize | verification only | Zurich-based valuemize has closed a seven-figure pre-seed round with participation from a consortium of VC offices and angel investors. | startupticker.ch |
Send the copied line to Claude or to Cowork, or open the file
and set "accepted": true on the ones you want. Either way the
next run moves them into corrections.json, where they apply to the whole
database and cannot be overruled.
A proposal with nothing quoted, or no source, should be refused: the evidence is the only reason to believe a check that a machine ran on itself.